Literature DB >> 11466585

Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans.

B Fruehwald-Schultes1, W Kern, J Born, H L Fehm, A Peters.   

Abstract

OBJECTIVE: Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis is frequently found in hyperinsulinemic subjects, such as patients with diabetes or abdominal obesity. Here, the question has been posed as to whether hyperinsulinemia increases HPA secretory activity.
METHODS: We performed paired-euglycemic and stepwise hypoglycemic (76-66-56-46 mg/dl)-clamp experiments in two groups (each of 15 healthy men) at different insulin infusions rates, ie, 1.5 mU/min/kg (low-insulin condition) and 15.0 mU/min/kg (high-insulin condition).
RESULTS: During the euglycemic clamp, the high rate insulin infusion increased plasma ACTH levels, whereas plasma ACTH levels remained essentially unchanged during the low-insulin condition (condition by time interaction, P=0.008). Likewise, serum cortisol levels were higher during the high- vs low-insulin condition (condition by time interaction, P=0.004). During the hypoglycemic clamp, plasma ACTH levels did not differ between the low- vs high-insulin condition, while serum cortisol levels were higher during the high- vs low-insulin condition at the beginning of the clamp (plasma glucose approximately 76 mg/dl; P=0.032).
CONCLUSION: Data indicate that hyperinsulinemia acutely increases HPA secretory activity in healthy men. This finding appears to be relevant to the pathogenesis of many clinical abnormalities associated which diabetes and abdominal adiposity, often referred to as the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466585     DOI: 10.1038/sj.ijo.0801695

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

1.  Body composition in young adults with inborn errors of protein metabolism--a pilot study.

Authors:  G Wilcox; B J G Strauss; D E M Francis; H Upton; A Boneh
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.

Authors:  Jill K Morris; Eric D Vidoni; Jonathan D Mahnken; Robert N Montgomery; David K Johnson; John P Thyfault; Jeffrey M Burns
Journal:  Neurobiol Aging       Date:  2015-12-01       Impact factor: 4.673

3.  MAP kinases couple hindbrain-derived catecholamine signals to hypothalamic adrenocortical control mechanisms during glycemia-related challenges.

Authors:  Arshad M Khan; Kimberly L Kaminski; Graciela Sanchez-Watts; Todd A Ponzio; J Brent Kuzmiski; Jaideep S Bains; Alan G Watts
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

Review 4.  Hyperinsulinemia Associated Depression.

Authors:  Haider Sarwar; Shafiya Imtiaz Rafiqi; Showkat Ahmad; Sruthi Jinna; Sawleha Arshi Khan; Tamanna Karim; Omar Qureshi; Zeeshan A Zahid; Jon D Elhai; Jason C Levine; Shazia J Naqvi; Juan C Jaume; Shahnawaz Imam
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2022-04-21

Review 5.  Brain insulin signaling and Alzheimer's disease: current evidence and future directions.

Authors:  Helgi B Schiöth; Suzanne Craft; Samantha J Brooks; William H Frey; Christian Benedict
Journal:  Mol Neurobiol       Date:  2011-12-29       Impact factor: 5.590

6.  Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.

Authors:  Michael T Nedelcovych; Alexandra J Gadiano; Ying Wu; Arena A Manning; Ajit G Thomas; Saja S Khuder; Seung-Wan Yoo; Jiadi Xu; Justin C McArthur; Norman J Haughey; David J Volsky; Rana Rais; Barbara S Slusher
Journal:  ACS Chem Neurosci       Date:  2018-01-04       Impact factor: 5.780

7.  Central insulin signaling modulates hypothalamus-pituitary-adrenal axis responsiveness.

Authors:  Angie C N Chong; Merly C Vogt; Alexis S Hill; Jens C Brüning; Lori M Zeltser
Journal:  Mol Metab       Date:  2014-12-10       Impact factor: 7.422

8.  The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol production.

Authors:  Roland H Stimson; Nor A Mohd-Shukri; Jennifer L Bolton; Ruth Andrew; Rebecca M Reynolds; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

Review 9.  Intranasal treatment of central nervous system dysfunction in humans.

Authors:  Colin D Chapman; William H Frey; Suzanne Craft; Lusine Danielyan; Manfred Hallschmid; Helgi B Schiöth; Christian Benedict
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.